Cohance Lifesciences: Grant of Stock Options to certain eligible employees of the Company and Allotment of Equity Shares pursuant…
Cohance Lifesciences (COHANCE) filed a disclosure titled "Grant of Stock Options to certain eligible employees of the Company and Allotment of Equity Shares pursuant to exercise of Stock Options". The company is valued at about ₹16,567 crore.
What happened
Cohance Lifesciences (COHANCE) filed a disclosure with the exchanges on 6 November 2026 at 01:14 PM titled "Grant of Stock Options to certain eligible employees of the Company and Allotment of Equity Shares pursuant to exercise of Stock Options".
Company snapshot
Cohance Lifesciences is a small-cap company in the Healthcare sector, with a market value of about ₹16,567 crore.
The stock last traded at ₹433.1, against a 52-week range of ₹266.7–₹744.3 (41.8% below the high).
Before this filing the shares had moved +0.8% over the month and +4.9% over three months. Average daily turnover over the last 20 sessions was about ₹35.7 crore.
Promoters held 57.49% at the end of Q1 FY27; 94.56% of promoter shares were pledged. Foreign institutions owned 6.50% and domestic institutions 20.09%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 549 | 48.9 | 1.28 |
| Q2 FY26 | 1,105 | 123 | 3.22 |
| Q3 FY26 | 545 | 36.7 | 0.96 |
| Q4 FY26 | 619 | 19.6 | 0.51 |
| Q1 FY27 | 422 | -24.1 | -0.63 |
What history shows
This is not the company's first fund raising disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Across 33 similar disclosures by other Healthcare companies, shares moved +0.8% on average the next day and +0.9% over five days; 55% of them rose the next day.
Market-wide, 1,733 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
- 6 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- COHANCE Stock Price and Chart — NSE:COHANCE
- Cohance Lifesciences: Can a recovery justify its valuation?
- Cohance Lifesciences manufacturing site in Telangana shut after worker dies in accident
- Cohance Lifesciences to Review September Quarter Results on Nov 6
- Cohance Lifesciences plant ordered shut in Telangana after employee dies in industrial accident
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.